title: ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Isimbaldi
authors.forename: Laura
authors.initials: L
authors.lastname: Bandiera
authors.forename: Emanuele S G
authors.initials: ES
authors.lastname: d'Amore
authors.forename: Valentino
authors.initials: V
authors.lastname: Conter
authors.forename: Marina
authors.initials: M
authors.lastname: Milani
authors.forename: Lara
authors.initials: L
authors.lastname: Mussolin
authors.forename: Angelo
authors.initials: A
authors.lastname: Rosolen
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002889:Chromosomes, Human, Pair 2 / Q000235:genetics; D002966:Clathrin / Q000235:genetics*; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D015321:Gene Rearrangement / Q000235:genetics*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011241:Prednisone / Q000008:administration & dosage; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D020794:Receptor Protein-Tyrosine Kinases; D014178:Translocation, Genetic / Q000235:genetics; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D002966:Clathrin; D015514:Oncogene Proteins, Fusion; D014750:Vincristine; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin